Gilead Sciences Trading assets decreased by 75.9% to $19.00M in Q3 2025 compared to the prior quarter.
An increase suggests higher market-making activity or a more aggressive proprietary trading stance.
These are financial instruments, such as stocks, bonds, and commodities, held by the firm for the purpose of short-term...
High for investment banks and global markets divisions; lower for pure retail banks.
fin_trading_assets| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.69B | $1.39B | $1.09B | $953.00M | $1.01B | $999.00M | $1.01B | $1.23B | $79.00M | $19.00M |
| QoQ Change | — | -17.6% | -21.9% | -12.2% | +5.8% | -0.9% | +0.8% | +21.7% | -93.6% | -75.9% |
| YoY Change | — | — | — | -43.5% | -27.5% | -8.0% | +5.7% | +21.6% | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.